Moneycontrol PRO
LAMF
LAMF

Ayushman Kumar

Principal Correspondent, Editorial And Content, Moneycontrol

Bivalent COVID-19 vaccines offer incremental benefits in elderly: Kang

TRENDS

Bivalent COVID-19 vaccines offer incremental benefits in elderly: Kang

India sees rise in Covid variants driving cases abroad, govt steps up surveillance

TRENDS

India sees rise in Covid variants driving cases abroad, govt steps up surveillance

COVID policy-making task force hasn’t met since April

TRENDS

COVID policy-making task force hasn’t met since April

INSACOG closely assessing situation, vigilant on COVID mutant: NK Arora

TRENDS

INSACOG closely assessing situation, vigilant on COVID mutant: NK Arora

Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal

TRENDS

Zydus, Baba Ramdev firm among 16 barred from selling drugs in Nepal

Dr Reddy’s completes phase 1 study of key anti-rheumatic biosimilar drug

TRENDS

Dr Reddy’s completes phase 1 study of key anti-rheumatic biosimilar drug

WHO says Swiss lab confirmed cough syrup contamination, but is silent on proof of causality

TRENDS

WHO says Swiss lab confirmed cough syrup contamination, but is silent on proof of causality

Biological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India

TRENDS

Biological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India

FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma

TRENDS

FDA's warning letter points to cGMP violations at Halol facility: Sun Pharma

Dr Reddy’s subsidiary Aurigene Oncology stops clinical trial for psoriasis drug in US

TRENDS

Dr Reddy’s subsidiary Aurigene Oncology stops clinical trial for psoriasis drug in US

Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt

INDIA

Gambian children’s death: Maiden Pharma’s cough syrups of standard quality, no contaminants found, says govt

Takeda expands rare disease portfolio in India, plans foray in oncology segment

INDIA

Takeda expands rare disease portfolio in India, plans foray in oncology segment

Chinese firms behind AIIMS Delhi server attack: Govt sources

INDIA

Chinese firms behind AIIMS Delhi server attack: Govt sources

Moderna, Merk’s mRNA cancer vaccine shows promising result in trials

TRENDS

Moderna, Merk’s mRNA cancer vaccine shows promising result in trials

Increase taxes on tobacco products, disincentivize consumption: Parliamentary panel to govt

INDIA

Increase taxes on tobacco products, disincentivize consumption: Parliamentary panel to govt

Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark

TRENDS

Committed to maintain highest quality, FDA warning letter on Bardez plant won’t impact supplies: Glenmark

Have firm plans to bring in drugs from global pipeline to tackle India’s NCD challenges: Gagandeep Singh Bedi, AstraZeneca India

INDIA

Have firm plans to bring in drugs from global pipeline to tackle India’s NCD challenges: Gagandeep Singh Bedi, AstraZeneca India

Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why

TRENDS

Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why

Stop YouTube learnings: Dental Council’s guidelines to maxillofacial surgeons for cosmetic procedures

TRENDS

Stop YouTube learnings: Dental Council’s guidelines to maxillofacial surgeons for cosmetic procedures

Viatris acquisition allows us to offer a full solution to healthcare systems globally: Biocon Biologics CEO 

TRENDS

Viatris acquisition allows us to offer a full solution to healthcare systems globally: Biocon Biologics CEO 

After AIIMS, hackers attack ICMR website 6,000 times in a day

TRENDS

After AIIMS, hackers attack ICMR website 6,000 times in a day

JB Pharma slashes price of critical heart failure medicine in India

BUSINESS

JB Pharma slashes price of critical heart failure medicine in India

Drug regulator stalls approval for sale of Biological E’s pneumococcal vaccine

TRENDS

Drug regulator stalls approval for sale of Biological E’s pneumococcal vaccine

AIIMS ransomware attack: Two system analysts suspended as officials scan 50 servers, 5K computers

BUSINESS

AIIMS ransomware attack: Two system analysts suspended as officials scan 50 servers, 5K computers

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347